Study of Anlotinib After Lenvatinib in Patients With Hepatocellular Carcinoma
Clinical trial NCT04080154 · UNKNOWN
Trial details
- NCT number
- NCT04080154
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-24
- Primary completion
- 2021-02-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.